Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells

Cell proliferation and differentiation are highly coordinated processes. These two processes are disrupted during leukemogenesis, resulting in differentiation block and uncontrolled proliferation in leukemia. To understand the mechanisms disrupting the coordination between the two processes in acute promyelocytic leukemia (APL), we investigated the regulatory mechanism of the negative cell cycle regulator CDKN2D by the promyelocytic leukemia/retinoic acid receptor α (PML/RARα) fusion protein and the role of CDKN2D in cell differentiation and proliferation. We found that CDKN2D expression in APL cells was significantly lower than that in normal promyelocytes. By chromatin immunoprecipitation and luciferase reporter assays, we showed that PML/RARα directly bound to and inhibited the transactivation of the CDKN2D promoter. Further evidence by the truncated and mutated CDKN2D promoters revealed that the everted repeat 8 (ER8) motif on the promoter was the binding site of PML/RARα. Forced expression of CDKN2D induced G0/G1 phase arrest and partial granulocytic differentiation in APL-derived NB4 cells, suggesting the function of CDKN2D in regulating both cell proliferation and granulocytic differentiation. Furthermore, all-trans retinoic acid (ATRA) significantly induced CDKN2D expression in APL cells and knockdown of CDKN2D expression during ATRA treatment partially blocked the ATRA-induced differentiation and cell cycle arrest. Collectively, our data indicate that CDKN2D repression by PML/RARα disrupts both cell proliferation and differentiation in the pathogenesis of APL, and induced expression of CDKN2D by ATRA alleviates the disruption of both processes to ensure treatment efficiency. This study provides a mechanism for coupling proliferation and differentiation in leukemic cells through the action of CDKN2D.

[1]  Pier Paolo Pandolfi,et al.  The Role of PML in Tumor Suppression , 2002, Cell.

[2]  J. Dick,et al.  Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC. , 2009, Blood.

[3]  Charles Auffray,et al.  Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[5]  J. Bartek,et al.  Distinct versus redundant properties among members of the INK4 family of cyclin‐dependent kinase inhibitors , 2000, FEBS letters.

[6]  M. Tomonaga,et al.  Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. , 1996, Leukemia.

[7]  A. Zelenetz,et al.  Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation , 2002 .

[8]  A. Skoultchi,et al.  Coordinating cell proliferation and differentiation. , 2001, Current opinion in genetics & development.

[9]  S. Wageningen,et al.  ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells , 2005, Leukemia.

[10]  A. Zelenetz,et al.  Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). , 1995, Blood.

[11]  C. Nerlov,et al.  Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1‐C/EBPα interaction , 2007, The EMBO journal.

[12]  B. Edgar,et al.  A double-assurance mechanism controls cell cycle exit upon terminal differentiation in Drosophila. , 2007, Developmental cell.

[13]  Daniel G. Tenen,et al.  Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.

[14]  E. Lam,et al.  The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. , 2001, Blood.

[15]  K. Drumea,et al.  Retinoic acid signaling in myelopoiesis , 2008, Current opinion in hematology.

[16]  D. Bluteau,et al.  P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. , 2008, Blood.

[17]  M. Fey,et al.  Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16β, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT‐PCR using a polycompetitive internal standard , 1997, British journal of haematology.

[18]  M. Luskin,et al.  The Expression Pattern of the Cell Cycle Inhibitor p19INK4d by Progenitor Cells of the Rat Embryonic Telencephalon and Neonatal Anterior Subventricular Zone , 2001, The Journal of Neuroscience.

[19]  N. Sharpless,et al.  The Regulation of INK4/ARF in Cancer and Aging , 2006, Cell.

[20]  John H. White,et al.  Convergence of vitamin D and retinoic acid signalling at a common hormone response element , 2006, EMBO reports.

[21]  Zhu Chen,et al.  Acute promyelocytic leukaemia: novel insights into the mechanisms of cure , 2010, Nature Reviews Cancer.

[22]  M. Roussel,et al.  Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases. , 1997, Blood.

[23]  Rakesh Nagarajan,et al.  High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. , 2009, The Journal of clinical investigation.

[24]  M. Minden,et al.  PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. , 2010, Cancer cell.

[25]  H. Stunnenberg,et al.  PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. , 2010, Cancer cell.

[26]  C. Buske,et al.  Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. , 2001, Blood.

[27]  D. Carrasco,et al.  Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. , 2007, Cancer research.

[28]  H. de Thé,et al.  Revisiting the differentiation paradigm in acute promyelocytic leukemia. , 2011, Blood.

[29]  A. Skoultchi,et al.  GATA-1 directly regulates p21 gene expression during erythroid differentiation , 2010, Cell cycle.

[30]  Daniel G Tenen,et al.  ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. , 2004, Blood.

[31]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[32]  P. Newburger,et al.  RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. , 2007, Blood.

[33]  John H. White,et al.  P19INK4D and Cell Death , 2006, Cell cycle.

[34]  J. Licht,et al.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.

[35]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[36]  M. Lübbert,et al.  Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1 alpha that augments transcriptional activity of CCAAT/enhancer-binding protein-alpha. , 2005, Leukemia.

[37]  B. Verhasselt,et al.  HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. , 2002, Blood.

[38]  W. Miller,et al.  CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. , 1999, The Journal of clinical investigation.

[39]  P. Pandolfi,et al.  Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression , 2001, The Journal of experimental medicine.

[40]  M. Lübbert,et al.  Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α , 2005, Leukemia.

[41]  T. Hirano,et al.  Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest. , 1997, Biochemical and biophysical research communications.

[42]  H. de Thé,et al.  PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation , 2004, The Journal of experimental medicine.

[43]  Zhen-yi Wang,et al.  Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.